AI Verdict
GILD has stronger fundamentals based on our AI analysis.
GILD vs HCA Fundamental Comparison
| Metric | GILD | HCA |
|---|---|---|
| Revenue | $29.4B | $75.6B |
| Net Income | $8.5B | $6.8B |
| Net Margin | 28.9% | 9.0% |
| ROE | 37.5% | N/A |
| ROA | 14.4% | 11.2% |
| Current Ratio | 1.55x | 0.97x |
| Debt/Equity | 1.10x | N/A |
| EPS | $6.78 | $28.33 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GILD vs HCA: Frequently Asked Questions
Is GILD or HCA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. GILD is rated BUY (82% confidence) while HCA is rated BUY (75% confidence). This is not investment advice.
How does GILD compare to HCA fundamentally?
GILEAD SCIENCES, INC. has ROE of 37.5% vs HCA Healthcare, Inc.'s N/A. Net margins are 28.9% vs 9.0% respectively.
Which stock pays higher dividends, GILD or HCA?
GILD has a dividend yield of N/A or no dividend while HCA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GILD or HCA for long term?
For long-term investing, consider that GILD has BUY rating with 82% confidence, while HCA has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GILD vs HCA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GILD vs HCA, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.